Phibro Animal Health (PAHC) vs Viatris (VTRS)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.
Summary
Viatris (VTRS) has outperformed Phibro Animal Health (PAHC) over the past year, gaining 76.6% versus a gain of 3.0%. Over five years, PAHC leads with a +75.7% price change compared with +31.1% for VTRS. Viatris is the larger company by market cap ($20.26 billion vs $1.56 billion), about 13.0 times the size, while Phibro Animal Health is growing revenue faster (+17.1% vs -3.0%).
On valuation, Viatris trades at a lower forward P/E (6.6x vs 10.0x for Phibro Animal Health). Viatris offers the higher dividend yield (2.72% vs 1.25%). Phibro Animal Health converts more of its revenue into profit, with a net margin of 6.6% versus -24.6%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | PAHC | VTRS |
|---|---|---|
| Share price | $38.30 | $17.64 |
| Market cap | $1.56B | $20.26B |
| 1-day change | +2.41% | +1.15% |
| YTD return | +2.52% | +41.69% |
| 1-year return | +3.04% | +76.58% |
| 5-year return | +75.69% | +31.05% |
| P/E ratio (TTM) | 15.76 | — |
| Forward P/E | 9.97 | 6.60 |
| EPS (TTM) | $2.43 | $-0.36 |
| Dividend yield | 1.25% | 2.72% |
| Annual dividend | $0.48 | $0.48 |
| Revenue (latest FY) | $1.52B | $14.30B |
| Revenue growth (YoY) | +17.12% | -2.98% |
| Net income (latest FY) | $99.72M | $-3.51B |
| Gross margin | 33.76% | 35.06% |
| Operating margin | 12.81% | -18.62% |
| Net margin | 6.57% | -24.58% |
| 52-week high | $60.08 | $18.43 |
| 52-week low | $28.25 | $9.73 |
| Distance from 52-week high | -36.25% | -4.29% |
| Analyst consensus | hold | buy |
| Avg. price target upside | +14.88% | +11.68% |
| Average volume | 231.66K | 9.27M |
| Shares outstanding | 21.11M | 1.15B |
| Employees | 2,605 | 30,000 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Viatris is about 13.0 times larger than Phibro Animal Health by market value ($20.26B vs $1.56B).
- VTRS has outperformed PAHC by 73.5 percentage points over the past year.
- Viatris offers a meaningfully higher dividend yield (2.72% vs 1.25%).
- Phibro Animal Health is more profitable, keeping 6.6 cents of every revenue dollar as net income versus -24.6 cents for Viatris.
- Phibro Animal Health grew revenue faster in its latest fiscal year (+17.12% vs -2.98%).
About Phibro Animal Health
PAHC stock →Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products.
Health Care · Biotechnology: Pharmaceutical Preparations · 2,605 employees
About Viatris
VTRS stock →Viatris Inc., together with its subsidiaries, operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East. It operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets.
Health Care · Biotechnology: Pharmaceutical Preparations · 30,000 employees
PAHC vs VTRS FAQ
Which is bigger, Phibro Animal Health or Viatris?
Viatris (VTRS) is larger, with a market capitalization of $20.26B compared with $1.56B for Phibro Animal Health (PAHC).
Which stock has performed better over the past year, PAHC or VTRS?
VTRS returned +76.58% over the past 12 months, compared with +3.04% for PAHC (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, Phibro Animal Health or Viatris?
Viatris has the higher yield at 2.72%, compared with 1.25% for Phibro Animal Health.
Are Phibro Animal Health and Viatris in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.